Study: Early phase of Moderna COVID-19 vaccine trial reveals more about immune response in older adu

757
33.3%
WPRI 1261.1K
Published on 30 Sep 2020, 10:59
An extension of Moderna's Phase I trial for its COVID-19 vaccine candidate shows promising results in older adults, with side effects reported as "predominantly mild or moderate in severity."
newstechmusickids